CD274 and neoplasm: Moreover, CAR-T cells may produce proinflammatory cytokines, increasing PD-L1 expression on tumor cells, and impairing the recruitment/sustained activation of effector T cells: immunomodulation is likely required to increase CAR T-cell efficacy against solid tumors [143].